Rafał Donderski

Analysis of profibrogenic microRNAs (miRNAs) expression in urine and serum of chronic kidney disease (CKD) stage 1–4 patients and their relationship with proteinuria and kidney function

Rafał Donderski, Joanna Szczepanek, Natalia Naruszewicz et al. · International Urology and Nephrology · 2021 · 28 citations · Full text

Medicine, Molecular Medicine, Nephrology +17

The rationale for Multilevel Educational and Motivational Intervention in Patients after Myocardial Infarction (MEDMOTION) project is to support multicentre randomized clinical trial Evaluating Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome (ELECTRA – SIRIO 2)

Aldona Kubica, Piotr Adamski, Anna Bączkowska et al. · Medical Research Journal · 2020 · 20 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

The Enhanced Renin-Angiotensin-Aldosteron System Pharmacological Blockade - Which is the Best?

Leszek Tylicki, Sławomir Lizakowski, Przemysław Rutkowski et al. · Kidney & Blood Pressure Research · 2012 · 18 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Analysis of Relative Expression Level of VEGF (<b><i>Vascular Endothelial Growth Factor</i></b>), HIF-1α (<b><i>Hypoxia Inducible Factor 1α</i></b>) and CTGF (<b><i>Connective Tissue Growth Factor</i></b>) Genes in Chronic Glomerulonephritis (CGN) Patients

Rafał Donderski, Joanna Szczepanek, Krzysztof Domagalski et al. · Kidney & Blood Pressure Research · 2013 · 17 citations · Full text

Medicine, Nephrology, Pathobiology +12

Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients

Rafał Donderski, Paweł Stróżecki, Beata Sulikowska et al. · International Urology and Nephrology · 2017 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17